Moderna on AWS
Founded in 2010, Moderna, Inc. is a biotechnology company pioneering a new class of messenger RNA (mRNA) medicines. Moderna has selected AWS as its preferred cloud provider, as well as its standard for analytics and machine learning workloads.
EXECUTIVE SUMMARY
Streamlining Real-World Data Extraction and Analysis by 70% Using AWS Data Exchange with Moderna
2023
Biotechnology company Moderna is creating a new generation of transformative medicine using mRNA technology. To power its intense workflows, the company needed to make its processes for ingesting, analyzing, and storing massive scientific datasets faster and more efficient.Moderna standardized its complete real-world data strategy on AWS. It’s using several AWS services alongside solutions from AWS Marketplace, a curated digital catalog that makes it easy to discover, procure, entitle, provision, and govern third-party data, software, and services to streamline data procurement.
Commercial Innovation at Moderna Using Amazon Connect and AI
2022
Moderna is changing the world of medicine by making mRNA medicines a reality. The company is also looking to redefine the global commercial experience and AWS has been its trusted cloud services provider throughout the journey. Listen to this session to learn how Moderna uses Amazon Connect to build next-generation, digital-first customer experiences with its unique, automated global contact center.
How Moderna and Takeda Accelerate Drug Research Using Real-World Data
2021
In life sciences, real-world data (RWD) is the foundation for drug discovery, development, and commercialization. In this session, two of the world’s leading life sciences organizations, Moderna and Takeda, walk you through why the companies adopted AWS Data Exchange and Amazon Redshift as integral components of their RWD strategies.
AWS Powers Moderna’s Digital Biotechnology Platform to Develop a New Class of Vaccines and Therapeutics
2021
In a pandemic, speed to market matters and Moderna was able to complete the sequence for its mRNA COVID-19 vaccine in just 2 days using machine learning built on AWS. The first clinical batch was released just 25 days later. Artificial intelligence (AI) algorithms enable drug development from rapid experimentation cycles to help design mRNA and DNA sequences to the automation of quality control analyses, saving hours of manual review of improvements across production processes and logistics. mRNA science has applicability beyond just one application, and Moderna is rapidly expanding into other infectious disease targets and modalities like oncology and autoimmune disease—using the flexible, programmable nature of mRNA, powered by machine learning, to revolutionize how diseases are treated.
Moderna
"The science behind mRNA medicines is advancing at a rapid pace, and building Moderna’s technology platform on AWS gives our scientists the insights, agility, and security they need to continue to lead in the industry.”
Stéphane Bancel
Chief Executive Officer, Moderna
Customer Success
Moderna Achieves Speed and Scale by Using AWS
2018
Dave Johnson, PhD, chief data and artificial intelligence (AI) officer at Moderna, discusses how building on AWS is helping the company achieve its goal of revolutionizing the way diseases are treated with mRNA therapy by providing speed, scale, and insights that can drive the business forward.
Modernizing Pharmaceutical Manufacturing with IoT and AI/ML at Moderna
Moderna, a “born in the cloud” pharma company, used AWS Internet of Things (IoT), AI/ML, and data analytics services to build a connected, intelligent biopharmaceutical manufacturing and supply chain environment. Moderna constructed a 200,000-square-foot Good Manufacturing Practices (GMP)–compliant manufacturing facility utilizing SAP S/4HANA and AWS services to facilitate a “batch of one,” resulting in an ISPE Facility of the Future Award.